Asma al-Assad, the first lady of Syria, has recently been diagnosed with leukaemia. This information was announced by the president of Syria on Tuesday, May 21, 2024. This new diagnosis comes five years after she recovered from breast cancer.
According to statements from the presidency, Asma, a 48-year-old lady, will undergo special treatment that will require her to be isolated from people and any social engagements.
Earlier on, the First Lady had already announced her full recovery from breast cancer in 2019, which was during the beginning of the Syrian War in 2011. Asma al-Assad is a British-born former investment banker by profession. She has hosted and led many charity campaigns and also interacted with the families of deceased soldiers. She has also faced many hostilities from her opposition, but these oppositions have not deterred her spirit for once.
Asma al-Assad, the first lady of Syria, is the current head of the Syria Trust for Development. This major non-governmental organisation controls all aid and development initiatives in the country.
Reports have it that during the late period of the just concluded year 2023, she and her husband, President Bashar al-Assad, visited the United Arab Emirates, which made it her first official foreign trip with her husband. It was during the course of the visitation that she met Sheikha Fatima bint Mubarak, who happens to be the mother of the Emirati President.
Currently, Asma al-Assad is being treated for a form of leukaemia, as was announced by the presidency on Tuesday, but her recovery will be dependent on a number of factors. The leukaemia expert said those will include either getting her treatment in Syria or abroad.
The leukaemia expert further said that Assad’s recovery will be dependent on some factors, including her chromosomes and the mutation in her body. The expert who refused to be named said that the first lady would need intensive chemotherapy and a stem cell, which is also known as a bone marrow transplant.
Discover more from Infodorm
Subscribe to get the latest posts sent to your email.